Jae Hoon Moon1, Young Joo Park, Tae Hui Kim, Ji Won Han, Sung Hee Choi, Soo Lim, Do Joon Park, Ki Woong Kim, Hak Chul Jang. 1. Department of Internal Medicine (J.H.M., S.H.C., S.L., H.C.J.) and Neuropsychiatry (T.H.K., J.W.H., K.W.K.), Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam 463-707, Korea; and Department of Internal Medicine (Y.J.P., D.J.P.), Seoul National University Hospital, Seoul National University College of Medicine, Seoul 110-799, Korea.
Abstract
CONTEXT: The association between subclinical hyperthyroidism and the risk of dementia has been validated in several studies. However, the effect of thyroid function within reference range on the risk of cognitive dysfunction including mild cognitive impairment (MCI) and dementia is still unclear. OBJECTIVE: Our aim was to investigate the association between thyroid function and the risk of MCI and dementia in euthyroid elderly subjects. DESIGN, SETTING, AND PARTICIPANTS: We conducted a population-based prospective study as a part of the Korean Longitudinal Study on Health and Aging. A total of 313 participants who were euthyroid and nondemented at baseline and completed cognitive function tests at a 5-year follow-up evaluation (mean age 72.5 ± 6.9 y) were analyzed in the present study. MAIN OUTCOME MEASURE: Baseline thyroid function was compared according to the development of MCI or dementia during the study period. Binary logistic regression analysis was performed to investigate the independent association between thyroid function and cognitive impairment. RESULTS: At baseline evaluation, 237 subjects were cognitively normal, and 76 subjects had MCI. Diagnoses of cognitive function in 259 subjects remained unchanged or improved during the study period (nonprogression group), whereas 54 subjects showed progression of cognitive impairment to MCI or dementia (progression group). In the progression group, baseline serum TSH levels were lower than those in nonprogression group. Baseline serum free T₄ levels were not significantly different between these two groups. The association between lower baseline serum TSH levels and the development of MCI or dementia was maintained after adjustment for conventional baseline risk factors. CONCLUSIONS: Lower serum TSH level within the reference range was independently associated with the risk of cognitive impairment including MCI and dementia in elderly subjects.
CONTEXT: The association between subclinical hyperthyroidism and the risk of dementia has been validated in several studies. However, the effect of thyroid function within reference range on the risk of cognitive dysfunction including mild cognitive impairment (MCI) and dementia is still unclear. OBJECTIVE: Our aim was to investigate the association between thyroid function and the risk of MCI and dementia in euthyroid elderly subjects. DESIGN, SETTING, AND PARTICIPANTS: We conducted a population-based prospective study as a part of the Korean Longitudinal Study on Health and Aging. A total of 313 participants who were euthyroid and nondemented at baseline and completed cognitive function tests at a 5-year follow-up evaluation (mean age 72.5 ± 6.9 y) were analyzed in the present study. MAIN OUTCOME MEASURE: Baseline thyroid function was compared according to the development of MCI or dementia during the study period. Binary logistic regression analysis was performed to investigate the independent association between thyroid function and cognitive impairment. RESULTS: At baseline evaluation, 237 subjects were cognitively normal, and 76 subjects had MCI. Diagnoses of cognitive function in 259 subjects remained unchanged or improved during the study period (nonprogression group), whereas 54 subjects showed progression of cognitive impairment to MCI or dementia (progression group). In the progression group, baseline serum TSH levels were lower than those in nonprogression group. Baseline serum free T₄ levels were not significantly different between these two groups. The association between lower baseline serum TSH levels and the development of MCI or dementia was maintained after adjustment for conventional baseline risk factors. CONCLUSIONS: Lower serum TSH level within the reference range was independently associated with the risk of cognitive impairment including MCI and dementia in elderly subjects.
Authors: Soo Heon Kwak; Young Joo Park; Min Jin Go; Kyu Eun Lee; Su-Jin Kim; Hoon Sung Choi; Tae Hyuk Kim; Sung Hee Choi; Soo Lim; Ki Woong Kim; Do Joon Park; Sung Soo Kim; Jong-Young Lee; Kyong Soo Park; Hak C Jang; Nam H Cho Journal: Hum Mol Genet Date: 2014-04-09 Impact factor: 6.150
Authors: Mary H Samuels; Rajani Kaimal; Avantika Waring; Howard A Fink; Kristine Yaffe; Andrew R Hoffman; Eric Orwoll; Douglas Bauer Journal: Thyroid Date: 2016-09 Impact factor: 6.568
Authors: Anne R Cappola; Alice M Arnold; Kendra Wulczyn; Michelle Carlson; John Robbins; Bruce M Psaty Journal: J Clin Endocrinol Metab Date: 2014-12-16 Impact factor: 5.958
Authors: Carole Rieben; Daniel Segna; Bruno R da Costa; Tinh-Hai Collet; Layal Chaker; Carole E Aubert; Christine Baumgartner; Osvaldo P Almeida; Eef Hogervorst; Stella Trompet; Kamal Masaki; Simon P Mooijaart; Jacobijn Gussekloo; Robin P Peeters; Douglas C Bauer; Drahomir Aujesky; Nicolas Rodondi Journal: J Clin Endocrinol Metab Date: 2016-09-30 Impact factor: 5.958
Authors: Mary H Samuels; Irina Kolobova; Anne Smeraglio; Meike Niederhausen; Jeri S Janowsky; Kathryn G Schuff Journal: Thyroid Date: 2016-07-25 Impact factor: 6.568
Authors: Peter T Nelson; Zsombor Gal; Wang-Xia Wang; Dana M Niedowicz; Sergey C Artiushin; Samuel Wycoff; Angela Wei; Gregory A Jicha; David W Fardo Journal: Neurobiol Dis Date: 2019-01-23 Impact factor: 5.996